- The administration of repeated low doses of psilocybin did not induce anxiety or compulsive behaviors in rats, suggesting a distinct profile for microdosing.
- Psilocybin microdosing increased resilience against stress and reduced self-grooming—a metric for compulsive actions—supporting potential therapeutic applications.
- Both 5-HT7 receptor expression and synaptic density in specific brain regions (paraventricular nucleus of the thalamus) were enhanced, hinting at a physiological mechanism for the behavioral changes observed.
Introduction
The serotonergic psychedelic prodrug, psilocybin, has garnered increasing attention as a candidate for treating conditions such as depression, end-of-life anxiety, and substance use disorders. Despite this growing interest, the scientific community has not extensively validated the efficacy and safety of prolonged psychedelic microdosing, although many individuals are exploring this approach for therapeutic benefits.
Psilocybin microdosing involves administering repeated low doses, typically around 10% of the conventional psychoactive dosage of 25 mg. Such dosages elicit measurable behavioral and pharmacological effects, creating a divergence from the more clinical definition of microdoses.
Study Objective
Given the lack of objective data in this domain, the researchers aimed to create a psilocybin dosing regimen mimicking typical microdosing while evaluating associated behavioral changes, specifically concerning anxiety and compulsivity. They tested the hypothesis asserting that repeated low doses would influence mood, anxiety, and compulsive-like behaviors in rats.
Methodology
The research utilized Long Evans rats, housed in controlled environments under a 12-hour light/dark cycle, with ad libitum food access but scheduled fasting for the sucrose preference tests. The dosing regimen involved administering 0.05 mg/kg of psilocybin subcutaneously every other day over a three-week period.
Behavioral assessments included various tests like open-field and elevated plus maze evaluations. Additionally, the pre-pulse inhibition (PPI) of the startle reflex and other metrics were explored to gauge potential alterations in stress and anxiety levels linked to drug administration.
Results Overview
Behavioral Effects
The findings revealed that microdosing with psilocybin did not lead to increased anxiety or overactive grooming behavior despite prolonged exposure. Instead, psilocybin microdosing appeared to reduce self-grooming, indicative of lower compulsive behaviors. Moreover, preference for sucrose—a marker for anhedonia—actually increased, signifying resistance to stress-induced emotional decline.
Physiological Changes
The results also indicated no significant reduction in locomotor activity or other behavioral impairments associated with anxiety in familiar environments. Furthermore, there were no indications of behavioral desensitization or receptor downregulation affecting the measured serotonin receptors. Instead, increased expression of the 5-HT7 receptor and synaptic density were noted in relevant regions of the brain, which could elucidate the mechanisms behind the behavioral changes observed.
Discussion
Microdosing psychedelics presents a novel and emerging field for possible neuropsychiatric treatment, enhancing the need for rigorous scientific exploration. The study’s design allowed for a clearer understanding of psilocybin’s effects through an animal model, thus reducing biases associated with human self-reports. The current regimen activated around 20% of the 5-HT2A receptors without producing any overt psychedelic effects, paving the way for further inquiries.
Overall, the study concluded that repeated low doses of psilocybin could potentially enhance resilience against stress-induced anhedonia and diminish compulsive behaviors, promising a viable therapeutic pathway for future research into microdosing applications in human subjects. The distinct enhancement of the 5-HT7 receptor’s involvement further points to a mechanistic understanding of psilocybin microdosing’s benefits, particularly regarding motivational behaviors relevant to mental health.
Read the full paper summary on Blossom.
